» Articles » PMID: 2952558

Immunological and Immunopathological Aspects of Opsin-induced Uveoretinitis

Overview
Specialty Ophthalmology
Date 1987 Jan 1
PMID 2952558
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

In an extension of our previous studies, experimental autoimmune uveoretinitis (EAU) was induced in Lewis rats by injection of very high doses of bovine opsin. The induced reaction consisted predominantly of a mild posterior retinitis. Varying the amount of injected opsin between 300 and 1,000 micrograms did not influence this result, provided that the antigen was injected in Freund's complete adjuvant. Pathogenicity of opsin appeared to be lower than that of interphotoreceptor retinoid binding protein (IRBP) or S-antigen, while EAU induced by the latter antigens was much more dose-dependent than EAU induced by opsin. An increase of the dose strongly accelerated the onset and increased the incidence of EAU from low to moderate. However, severe inflammation and high incidence were only obtained by co-injection of Hemophilus pertussis bacteria. This adjuvant especially increased cellular immune responses to opsin as measured by lymphocyte transformation. No marked effects on humoral responses were detected by ELISA, using different types of opsin preparations. Development of opsin-induced EAU was inhibited by ciclosporin, a suppressor of certain specific T cell functions. Ciclosporin injections lowered the antibody response of the rats and eliminated measurable lymphocyte transformation in vitro. Induction of opsin-EAU therefore appears to be T-cell-dependent. The effect of pertussis adjuvant may be explained by enhancement of the T cell responses to opsin and by increasing the permeability of the blood-retina barriers. Other properties of the adjuvant may be of importance as well. A relationship between change in molecular conformation and uveitogenicity of opsin is discussed.

Citing Articles

Protein Biomarkers in Uveitis.

Bansal R, Gupta A Front Immunol. 2020; 11:610428.

PMID: 33343583 PMC: 7744561. DOI: 10.3389/fimmu.2020.610428.


Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Faulds D, Goa K, Benfield P Drugs. 1993; 45(6):953-1040.

PMID: 7691501 DOI: 10.2165/00003495-199345060-00007.


Immune responsiveness to retinal S-antigen and opsin in serpiginous choroiditis and other retinal diseases.

Broekhuyse R, Van Herck M, Pinckers A, Winkens H, Van Vugt A, Ryckaert S Doc Ophthalmol. 1988; 69(1):83-93.

PMID: 2971518 DOI: 10.1007/BF00154420.


Experimental autoimmune uveoretinitis in rats induced by rod visual pigment: rhodopsin is more pathogenic than opsin.

Schalken J, Van Vugt A, Winkens H, de Grip W, Broekhuyse R Graefes Arch Clin Exp Ophthalmol. 1988; 226(3):255-61.

PMID: 2969840 DOI: 10.1007/BF02181192.


Rhodopsin-induced experimental autoimmune uveoretinitis in monkeys.

Schalken J, Winkens H, Van Vugt A, de Grip W, Broekhuyse R Br J Ophthalmol. 1989; 73(3):168-72.

PMID: 2706205 PMC: 1041684. DOI: 10.1136/bjo.73.3.168.


References
1.
Nussenblatt R, Waksman B, Gery I . Cyclosporin A: alterations of the cellular immune response in S-antigen-induced experimental autoimmune uveitis. Int Arch Allergy Appl Immunol. 1983; 70(4):289-94. DOI: 10.1159/000233339. View

2.
Broekhuyse R, Winkens H, Kuhlmann E . Induction of experimental autoimmune uveoretinitis and pinealitis by IRBP. Comparison to uveoretinitis induced by S-antigen and opsin. Curr Eye Res. 1986; 5(3):231-40. DOI: 10.3109/02713688609020048. View

3.
Broekhuyse R, Winkens H, Kuhlmann E, Van Vugt A . Opsin-induced experimental autoimmune retinitis in rats. Curr Eye Res. 1984; 3(12):1405-12. DOI: 10.3109/02713688409000836. View

4.
Schalken J, Van Vugt A, Winkens H, de Grip W, Broekhuyse R . Experimental autoimmune uveoretinitis in rats induced by rod visual pigment: rhodopsin is more pathogenic than opsin. Graefes Arch Clin Exp Ophthalmol. 1988; 226(3):255-61. DOI: 10.1007/BF02181192. View

5.
Arnon R . Experimental allergic encephalomyelitis--susceptibility and suppression. Immunol Rev. 1981; 55:5-30. DOI: 10.1111/j.1600-065x.1981.tb00337.x. View